Is ELV or PGNY more undervalued in 2026?

CirclFi compares Elevance Health, Inc. (ELV) and Progyny, Inc. (PGNY) using 13 institutional-grade valuation models. ELV has a Quality of Company score of 9.2/10 while PGNY scores 8.8/10.

Which is a better buy — ELV or PGNY?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ELV and PGNY valuations compare?

ELV at $392.75 and PGNY at $25.69 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ELV vs PGNY Valuation Comparison 2026 — Intrinsic Value Analysis

ELV

Healthcare Plans

Elevance Health, Inc.

Quality

9.2

out of 10

Value Trap

—

Price

$392.75

Last close

Models

12/13

Active

PGNY

Healthcare Plans

Progyny, Inc.

Quality

8.8

out of 10

Value Trap

SAFE

Price

$25.69

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	ELV Fair Value	ELV Upside	PGNY Fair Value	PGNY Upside
Bayesian DCF	Intrinsic	$268.95	-31.5%	$32.54	+26.7%
Earnings Power Value	Intrinsic	$197.44	-49.7%	$7.96	-69.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ELV vs PGNY — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ELV vs PGNY — Which Stock Is More Undervalued?

ELV scores higher with a 9.2/10 quality rating vs PGNY's 8.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Elevance Health, Inc. (ELV) and Progyny, Inc. (PGNY) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ELV currently trades at $392.75 with a QOC of 9.2/10, while PGNY trades at $25.69 with a QOC of 8.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).